Patent Assignment
Reel/Frame 052764/0578
Merger
Recorded: 2020-05-27
Pages: 4
Assignor
CAVION LLC
Executed: 2016-12-22
Assignee
CAVION, INC.
600 EAST WATER STREET, SUITE E, CHARLOTTESVILLE, VIRGINIA, 22902
Covered Property
(1)
Antagonists of Products of the HS.459642 Unigene Cluster for the Inhibition of Proliferation, Development or Differentiation of Stem Cells Including Cancer Stem Cells
Application:
16/685,279 →
Publication:
US 2020/0197516
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 1, 2020
From: GRAY, LLOYD S.
To: TAU THERAPEUTICS LLC
Reel/Frame 052547/0942 →
Change of Name
May 15, 2020
From: THA THERAPEUTICS LLC
To: CAVION LLC
Reel/Frame 052669/0527 →
Corrective Assignment to Correct the Correct Conveying Party Data Previously Recorded at Reel: 052669 Frame: 0527. Assignor(S) Hereby Confirms the Assignment.
Jun 1, 2020
From: TAU THERAPEUTICS LLC
To: CAVION LLC
Reel/Frame 052798/0351 →
Security Agreement
May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →